GSK_ Annual_Report_2021-22

49 There remains a relatively lesser scope in the healthcare industry for recycling. However, there is a mechanism to segregate the waste given to the authorised vendor for recycling, wherever appropriate. Globally, we look forward to working across our value chain - from discovery to disposal - to deliver reduction in environmental impact. Your Company follows the GSK Manufacturing Practices guidelines with respect to product packaging. Your Company’s products have various anti-counterfeiting and anti-pilferage measures such as barcodes and unique codes for products which are reviewed from time to time. Employee health and wellbeing Your Company believes in delivering performance by investing in and supporting its people. Your Company has a range of health and well being programmes and support services to help employees understand how to feel better and more energised at work and at home. These programmes focus mainly on five key elements – physical health, mental well being, nutrition, preventive health screening, and de-addiction. Your Company provides support to this programme by making investments, engaging senior leadership and subject matter experts who can provide directive guidelines for the programmes, and establish its tracking and monitoring system. Employee Assistance Programme (EAP) and Partnership for Prevention (P4P) are the main modes of intervention offered to employees and their family members. EAP is a 24/7 independent counselling service available to all employees and their family members in multiple languages, accessible online and through mobile apps and helplines. P4P offers eight types of preventive healthcare services – adult and child immunisation, adult and child preventive care, de-addiction support, heart and diabetes care, women’s health support, and cancer screening. Your Company, in the year under consideration, not only sustained its offerings under the P4P but also included two additional vaccines under the flu category to the offering. The medical insurance benefits offered to employees were reviewed in light of the Covid pandemic, and coverage was expanded for better protection against Covid, including covering home quarantine expenses. Your Company is committed to conducting its operations in a responsible manner to protect its employees, the environment, and the communities in which it operates. Extensive work has been carried out at the Nashik site as well as amongst the sales force to train and create awareness on employee health and safety. Safety training has been imparted to employees, temporary employees, and those with disabilities at the Company’s Nashik manufacturing facility in the last year. Your Company introduced 12 ‘Life Saving Rules’ which are designed to be simple tenets to live by and keep in mind for our employees across offices, the field, the manufacturing sites or even on their way back home with an emphasis on road safety. Your Company has also developed a global driver safety programme - Safe Driving: Every Journey Counts - for the safety of its employees in the field force. This initiative aims at increasing awareness on road and motor-vehicle safety, and training employees in bolstering defensive driving skills. Stakeholder engagement Engaging and building trust with the broad range of stakeholders who interact with or are impacted by your Company’s business is key to delivering its strategy, and ensuring the success of your Company over the long term. Patients and consumers How your Company engages with patients — Interactions with Health Care Professionals (HCPs) help shed light on patient needs — Market research helps to uncover consumer insights What matters — The pricing of healthcare products, particularly out-of-pocket expenses — Product innovation — Access to a reliable supply of high-quality, safe products What your Company is doing — GSK takes a values-based approach to pricing to balance reward for innovation, with access and affordability — GSK is strengthening its pipeline to bring innovative products to patients and to ensure that the Company maintains high standards for product quality and safety Investors Your Company maintains regular and constructive dialogue with investors to communicate its strategy and performance in order to promote investor confidence. How your Company engages with investors — Annual General Meeting — Analysts’ Meet — Detailed Company information made available online — One-to-one meetings between institutional investors and Managing Director and Chief Financial Officer What matters — Financial performance and commercial success — Management of key environmental, social and governance issues to mitigate risk and create opportunities What your Company is doing — Continuing to report, in line with the best practice disclosure on progress towards strategic goals — Specific business and R&D updates